Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.28 USD | +2.19% |
|
+4.42% | -11.12% |
12/07 | Morgan Stanley Adjusts Henry Schein's Price Target to $60 From $65 | MT |
09/07 | Leerink Partners Adjusts Price Target on Henry Schein to $72 From $77, Maintains Market Perform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.12% | 843.09Cr | |
+11.32% | 145.16Cr | |
-3.78% | 135.68Cr | |
-26.62% | 105.72Cr | |
-39.12% | 66Cr | |
-.--% | 62Cr | |
+5.60% | 47Cr | |
+1.70% | 43Cr | |
-39.25% | 27Cr | |
-68.10% | 23Cr |
- Stock Market
- Equities
- HSIC Stock
- News Henry Schein, Inc.
- Transcript : Henry Schein, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-08-2013 09